BioCatalystWatch
ACADWorkspace / ACAD / OverviewCompany library
ACADIA PHARMACEUTICALS INC logo

ACADIA PHARMACEUTICALS INC

ACADIA PHARMACEUTICALS INC (ACAD)

Website

Price
Market cap
Next catalystExpected 2026Remlifanserin (ACP-204) · Phase 2 dataCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

NMDA receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Trofinetide — Japan

Upcoming / outlook

  • Timing and evidence

5-HT2A receptor

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ACP-711

GABAA receptor α3 subunit

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Trofinetide — Japan

Upcoming / outlook

  • Timing and evidence

NMDA receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

5-HT2A receptor

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

ACP-711

GABAA receptor α3 subunit

Upcoming / outlook

  • Timing and evidence

Other pipelines

Approved / commercial

5-HT2A receptor

Approved

PreINDP1P2P3FilingApproved

Approved

PreINDP1P2P3FilingApproved

History / paused

5-HT2A receptor

PreINDP1P2P3FilingApproved

5-HT2A receptor

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ACAD PR & News

PR & News

ACAD SEC archive